https://www.zonebourse.com/cours/action/LEXARIA-BIOSCIENCE-CORP-25530934/actualite/Lexaria-Bioscience-Corp-annonce-l-autorisation-de-la-FDA-pour-son-essai-clinique-de-phase-1b-sur-l-46078407/?utm_source=telegram&utm_medium=social&utm_campaign=share